Tori Rodriguez, MA, LPC, AHC

This report reviews the challenges patients with bladder cancer experience related to cystectomy and urinary diversion surgery.

Timely discussions about end-of-life preferences can ensure patients with advanced cancer receive care that aligns with their goals, experts say.

Aggregated data can hide disparities in cancer incidence and outcomes among Asian and Native Hawaiian/Pacific Islander patients in the US.

AML research presented at ASH 2022 highlighted promising combination regimens and suggested that some patients may benefit from less intensive treatment.

Experts discuss the challenges and potential resolutions for increasing diversity of clinical trial study populations.

Long-term cumulative exposure to air pollution should be included in assessments of lung cancer risk, according to researchers.

Recent exposure to systemic treatment does not increase the risk of 30-day mortality in patients with thoracic cancers and COVID-19.

Researchers found that 77% of patients had moderate to severe sexual dysfunction.

Sugemalimab consolidation improved progression-free survival, when compared with placebo, in patients with unresectable, stage III non-small cell lung cancer.

Adding nivolumab to neoadjuvant platinum-based chemotherapy can improve survival in patients with stage IIIA-B non-small cell lung cancer, new data suggest.